Your browser doesn't support javascript.
loading
Bacterial translocation is reduced by a specific nutritional combination in mice with chemotherapy-induced neutropenia.
Faber, Joyce; van Limpt, Kees; Kegler, Diane; Luiking, Yvette; Garssen, Johan; van Helvoort, Ardy; Vos, Arjan Paul; Knol, Jan.
Afiliación
  • Faber J; Nutricia Advanced Medical Nutrition, Danone Research, Centre for Specialised Nutrition, Wageningen, The Netherlands 6704 PH. joyce.faber@danone.com
J Nutr ; 141(7): 1292-8, 2011 Jul.
Article en En | MEDLINE | ID: mdl-21562235
Immune function is compromised in many cancer patients, leading to an increased risk of (infectious) complications. Chemotherapy-induced neutropenia is a common cause of treatment-induced immune suppression. In the present study, the effect of a specific nutritional combination (SNC) on bacterial translocation was studied in a model of chemotherapy-induced neutropenia in C3H/HeN mice colonized with Pseudomonas aeruginosa PAO-1. Dietary intervention started after stable colonization with P. aeruginosa to compare the SNC containing high protein, l-leucine, fish oil, and specific oligosaccharides to an isoenergetic control diet. After 3 wk, the mice were treated with cyclophosphamide to induce neutropenia. This rendered the mice susceptible to Pseudomonas translocation, which was quantified 5 d later. Intervention with the SNC resulted in a reduced incidence and intensity of bacterial translocation to the liver (P < 0.05) and a similar trend in the lungs (P ≤ 0.057). In addition, the SNC reduced the fecal pH (P < 0.05) and decreased P. aeruginosa counts in fecal samples (P < 0.05). Moreover, plasma concentrations of proinflammatory cytokines were correlated with the reduced bacterial translocation to the liver (ρ > 0.78; P < 0.001). In conclusion, dietary intervention with the SNC significantly reduced the incidence and severity of P. aeruginosa translocation in a mouse model of chemotherapy-induced immune suppression. Several mechanisms might have played a role, including the modulation of the intestinal microbiota, an improved gut barrier function, immune function, and a reduced inflammatory state. These results suggest an opportunity to develop new applications in cancer patients, with the aim to reduce infectious and other complications.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pseudomonas aeruginosa / Traslocación Bacteriana / Neutropenia Tipo de estudio: Evaluation_studies Idioma: En Revista: J Nutr Año: 2011 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pseudomonas aeruginosa / Traslocación Bacteriana / Neutropenia Tipo de estudio: Evaluation_studies Idioma: En Revista: J Nutr Año: 2011 Tipo del documento: Article